Barclays’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-79,034
| Closed | -$8.06M | – | 4455 |
|
|
2023
Q2 | $8.06M | Buy |
79,034
+62,278
| +372% | +$6.35M | 0.01% | 977 |
|
|
2023
Q1 | $1.52M | Buy |
16,756
+886
| +6% | +$80.5K | ﹤0.01% | 1842 |
|
|
2022
Q4 | $603K | Buy |
15,870
+2,008
| +14% | +$76.3K | ﹤0.01% | 2480 |
|
|
2022
Q3 | $348K | Sell |
13,862
-1,769
| -11% | -$44.4K | ﹤0.01% | 2775 |
|
|
2022
Q2 | $475K | Sell |
15,631
-13,279
| -46% | -$404K | ﹤0.01% | 2611 |
|
|
2022
Q1 | $948K | Sell |
28,910
-31,981
| -53% | -$1.05M | ﹤0.01% | 2361 |
|
|
2021
Q4 | $1.61M | Buy |
60,891
+35,192
| +137% | +$929K | ﹤0.01% | 1919 |
|
|
2021
Q3 | $2.59M | Buy |
25,699
+20,801
| +425% | +$2.09M | ﹤0.01% | 1679 |
|
|
2021
Q2 | $693K | Sell |
4,898
-2,959
| -38% | -$419K | ﹤0.01% | 2310 |
|
|
2021
Q1 | $784K | Buy |
7,857
+5,816
| +285% | +$580K | ﹤0.01% | 2427 |
|
|
2020
Q4 | $252K | Sell |
2,041
-302
| -13% | -$37.3K | ﹤0.01% | 2609 |
|
|
2020
Q3 | $229K | Sell |
2,343
-17,586
| -88% | -$1.72M | ﹤0.01% | 2672 |
|
|
2020
Q2 | $3.11M | Sell |
19,929
-11,682
| -37% | -$1.82M | ﹤0.01% | 1198 |
|
|
2020
Q1 | $4.56M | Sell |
31,611
-2,794
| -8% | -$403K | ﹤0.01% | 915 |
|
|
2019
Q4 | $7.03M | Buy |
34,405
+24,495
| +247% | +$5.01M | ﹤0.01% | 1019 |
|
|
2019
Q3 | $796K | Sell |
9,910
-3,062
| -24% | -$246K | ﹤0.01% | 2383 |
|
|
2019
Q2 | $1.22M | Sell |
12,972
-785
| -6% | -$74.1K | ﹤0.01% | 2188 |
|
|
2019
Q1 | $1.18M | Buy |
13,757
+4,173
| +44% | +$357K | ﹤0.01% | 2028 |
|
|
2018
Q4 | $537K | Buy |
9,584
+2,511
| +36% | +$141K | ﹤0.01% | 2217 |
|
|
2018
Q3 | $578K | Buy |
7,073
+5,905
| +506% | +$483K | ﹤0.01% | 2569 |
|
|
2018
Q2 | $41K | Sell |
1,168
-3,048
| -72% | -$107K | ﹤0.01% | 3355 |
|
|
2018
Q1 | $87K | Buy |
4,216
+720
| +21% | +$14.9K | ﹤0.01% | 3229 |
|
|
2017
Q4 | $99K | Sell |
3,496
-432
| -11% | -$12.2K | ﹤0.01% | 3009 |
|
|
2017
Q3 | $122K | Buy |
3,928
+3,734
| +1,925% | +$116K | ﹤0.01% | 2623 |
|
|
2017
Q2 | $6K | Buy |
194
+16
| +9% | +$495 | ﹤0.01% | 3524 |
|
|
2017
Q1 | $4K | Sell |
178
-803
| -82% | -$18K | ﹤0.01% | 3684 |
|
|
2016
Q4 | $21K | Buy |
981
+944
| +2,551% | +$20.2K | ﹤0.01% | 3075 |
|
|
2016
Q3 | $1K | Sell |
37
-6,047
| -99% | -$163K | ﹤0.01% | 3824 |
|
|
2016
Q2 | $120K | Buy |
+6,084
| New | +$120K | ﹤0.01% | 2276 |
|